Manríquez RM, Pérez RJ, Miguel GM, Pérez BG

Language: Spanish
References: 5
Page: 171-174
PDF size: 250.37 Kb.

ABSTRACT

Secondary erythrocytosis in adults with cyanotic congenital heart disease causes important morbidity because of complications of hyperviscosity; they experience symptoms caused by adverse effects of hypervicosity on different tissues. The association between elevated hematocrit and thrombosis has not been established in secondary erythrocytosis to hypoxemia. Phlebotomy provides temporary improvement but leads to iron deficiency and can increase blood viscosity. We present a case report of an 18 year old patient who debuts with symptoms of hyperviscosity owed to erythrocytosis and during his diagnostic approach was identified congenital cardiopaty as etiology.

REFERENCES

1. Perloff JK, Marelli AJ, Miner PD. Risk of stroke in adults with cyanotic congenital heart disease. Circulation 1993;87:1954-1959.

2. Reiss UM, Bensimhon P, Zimmerman SA, Ware RE. Hydroxyurea therapy for management of secondary erythrocytosis in cyanotic congenital heart disease. Am J Hematol 2007;82:740- 743.

3. Landzberg MJ. Congenital hear disease associated pulmonary arterial hypertension. Clin Chest Med 2007;28:243-253.

4. Rose SS, Shah AA, Hoover DR, Saidi P. Cyanotic congenital heart disease (CCHD) with symptomatic erytrocytosis. J Gen Intern Med 2007;22:1775-1777.

5. Patnaik MM, Tefferi A. The complete evaluation of erythrocytosis: congenital and adquired. Leukemia 2009;23:834-44.